Mon, July 1, 2024
Fri, June 28, 2024
Thu, June 27, 2024
Wed, June 26, 2024
Tue, June 25, 2024

Sumant Kulkarni Maintained (BTAI) at Strong Buy and Held Target at $7 on, Jun 27th, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. g-buy-and-held-target-at-7-on-jun-27th-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Sumant Kulkarni of Canaccord Genuity, Maintained "BioXcel Therapeutics, Inc." (BTAI) at Strong Buy and Held Target at $7 on, Jun 27th, 2024.

Sumant has made no other calls on BTAI in the last 4 months.



There are 2 other peers that have a rating on BTAI. Out of the 2 peers that are also analyzing BTAI, 0 agree with Sumant's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Sumant


  • Raghuram Selvaraju of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $10 on, Friday, May 10th, 2024
  • Geoff Meacham of "B of A Securities" Maintained at Strong Buy with Decreased Target to $7 on, Wednesday, March 13th, 2024

Publication Contributing Sources